Literature DB >> 6791232

Prostaglandin synthetase inhibitors antagonize hypothermia induced by sedative hypnotics.

F R George, S J Jackson, A C Collins.   

Abstract

Previous studies in our laboratory have demonstrated that inhibition of prostaglandin biosynthesis through pretreatment with aspirin and other prostaglandin synthetase inhibitors (PGSI) significantly reduces CNS sensitivity to a hypnotic dose of ethanol. Indomethacin, a potent PGSI, was administered to male LS, SS, and HS/Ibg mice (65 +/- 10 days of age) 15 min prior to administration of a hypnotic dose of ethanol or pentobarbital. Doses of indomethacin used were identical to those previously reported as optimally antagonizing ethanol-induced sleep. Another group received a vehicle-control injection, while a third group also received a control injection, but were placed in a incubator maintained at 30 +/ 1 degrees C. Body temperatures were recorded periodically for several hours. Both indomethacin and incubation significantly reduced hypothermia induced by ethanol and pentobarbital. Incubation increased sleep time after ethanol, but did not affect pentobarbital sleep time. These results suggest that the hypnotic and hypothermic effects of ethanol, although possibly mediated through prostaglandins, apparently are not causally linked.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6791232     DOI: 10.1007/BF00427102

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  12 in total

Review 1.  Regulation of noradrenaline release by presynaptic receptor systems.

Authors:  K Starke
Journal:  Rev Physiol Biochem Pharmacol       Date:  1977       Impact factor: 5.545

2.  Adrenocortical function in mice selectively bred for different sensitivity to ethanol.

Authors:  R Kakihana
Journal:  Life Sci       Date:  1976-05-15       Impact factor: 5.037

Review 3.  Prostaglandins and the central nervous system.

Authors:  F Coceani
Journal:  Arch Intern Med       Date:  1974-01

4.  Stimulation of prostaglandin biosynthesis by drugs: effects in vitro of some drugs affecting gut function.

Authors:  H O Collier; W J McDonald-Gibson; S A Saeed
Journal:  Br J Pharmacol       Date:  1976-10       Impact factor: 8.739

5.  Ethanol and prostaglandin E1: biochemical and behavioral interactions.

Authors:  J Rotrosen; D Mandio; D Segarnick; L J Traficante; S Gershon
Journal:  Life Sci       Date:  1980-06-02       Impact factor: 5.037

6.  Effect of prostaglandin E 2 on central and peripheral catecholamine neurons.

Authors:  S Bergström; L O Farnebo; K Fuxe
Journal:  Eur J Pharmacol       Date:  1973-03       Impact factor: 4.432

7.  Body temperature responses at different ambient temperatures following injections of prostaglandin E1 and noradrenaline into the brain.

Authors:  W L Veale; I Q Whishaw
Journal:  Pharmacol Biochem Behav       Date:  1976-02       Impact factor: 3.533

8.  Prostaglandin synthetase inhibitors antagonize the depressant effects of ethanol.

Authors:  F R George; A C Collins
Journal:  Pharmacol Biochem Behav       Date:  1979-06       Impact factor: 3.533

9.  Body temperature in mice: a quantitative measure of alcohol tolerance and physical dependence.

Authors:  R F Ritzmann; B Tabakoff
Journal:  J Pharmacol Exp Ther       Date:  1976-10       Impact factor: 4.030

10.  Systemic administration of prostaglandin E1 produces hypothermic effects in unanesthetized rats.

Authors:  M T Lin
Journal:  J Pharmacol Exp Ther       Date:  1979-06       Impact factor: 4.030

View more
  3 in total

1.  Ethanol and indomethacin interactions in motor impairment, hypnosis, and body temperature.

Authors:  H B Greizerstein
Journal:  Psychopharmacology (Berl)       Date:  1984       Impact factor: 4.530

2.  Indomethacin does not antagonize the anxiolytic action of ethanol in the elevated plus-maze.

Authors:  R L Hale; A L Johnston; H C Becker
Journal:  Psychopharmacology (Berl)       Date:  1990       Impact factor: 4.530

3.  Modification of ethanol-induced motor impairment by diet, diuretic, mineralocorticoid, or prostaglandin synthetase inhibitor.

Authors:  L A Grupp; J Elias; E Perlanski; R B Stewart
Journal:  Psychopharmacology (Berl)       Date:  1985       Impact factor: 4.530

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.